论文部分内容阅读
1998年以来,价格管理部门针对“三项体制改革”与药品价格中存在的矛盾,不断出台配套措施与缓和药价矛盾的具体政策。但患者的医疗费用包括药品费用负担仍然沉重,从一般患者到政府各相关管理部门,都认为目前的药品价格政策不完善,是其中的一个重要原因。当前药品价格的主要矛盾是什么,对药价政策形成什么性质的压力?造成这种状况的原因是什么?如何从纷繁复杂的药价矛盾中理清头绪,找出完善当前药品价格政策的思路?我们经过对相关企业与部门的调查,以及对相关资料的分析,试图探讨以上问题。
Since 1998, in response to the contradictions in the “three system reforms” and drug prices, the price management department has continuously introduced concrete measures on contradictions between supporting measures and easing drug prices. However, the patient’s medical expenses, including the burden of drug costs are still heavy, from the general patient to the relevant government departments, all think the current drug price policy is not perfect, is one of the important reasons. What are the main reasons for the current price of pharmaceuticals and the nature of the drug price policy? What are the reasons for this situation? How to sort out the clues from the complex drug price conflicts and find out the way to improve the current drug price policy? ? After our investigation of relevant enterprises and departments, as well as the analysis of relevant information, we tried to explore the above issues.